Tagrisso specialty pharmacy?

Tagrisso (osimertinib) is a high‑cost oral cancer medicine. It’s not tied to one single “Tagrisso specialty pharmacy”—instead, it’s usually dispensed through a specialty pharmacy network that your insurer or the prescriber uses. The process is often: the oncologist writes the prescription → the specialty pharmacy handles prior authorization, insurance coordination, and monthly shipping.

What you might want to know or do next:
- Check with your oncologist or their clinic team which specialty pharmacy they use for Tagrisso.
- Contact your health insurance plan to confirm coverage and whether you’ll be required to use a particular specialty pharmacy.
- Ask about prior authorization requirements and what documentation is needed (diagnosis, labs, etc.).
- Inquire about patient assistance programs and co-pay help from the manufacturer (AstraZeneca) or from the insurer’s patient support options.
- If you’d like, tell me your location and insurer (or plan name), and I can outline the likely options and what to ask.

If you want, I can also give you a short checklist or sample questions to bring to your doctor or pharmacist.